However, this potential alteration, that is, the difference of HTT mRNA levels between the CAG19 and CAG19–10d treatments, did not reach statistical significance ( Fig. 2C , CAG19 -10d).
← all excerpts
Oligonucleotides Targeting DNA Repeats Downregulate <i>Huntingtin</i> Gene Expression in Huntington's Patient-Derived Neural Model System.
1
—
—